Invention Grant
US09017671B2 Method of treating cancer with a pharmaceutical formulation comprising a HER2 antibody
有权
用包含HER2抗体的药物制剂治疗癌症的方法
- Patent Title: Method of treating cancer with a pharmaceutical formulation comprising a HER2 antibody
- Patent Title (中): 用包含HER2抗体的药物制剂治疗癌症的方法
-
Application No.: US13660114Application Date: 2012-10-25
-
Publication No.: US09017671B2Publication Date: 2015-04-28
- Inventor: James Andya , Shiang C. Gwee , Jun Liu , Ye Shen
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Wendy M. Lee
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C07K16/32
Abstract:
The present application describes antibody formulations, including monoclonal antibodies formulated in histidine-acetate buffer, as well as a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab).
Public/Granted literature
- US20130071384A1 ANTIBODY FORMULATIONS Public/Granted day:2013-03-21
Information query
